Amylyx Pharmaceuticals (AMLX)
(Delayed Data from NSDQ)
$13.31 USD
+0.06 (0.45%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $13.32 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Amylyx Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AMLX 13.31 +0.06(0.45%)
Will AMLX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AMLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMLX
Wall Street Analysts See a 105.22% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?
PSTV Stock Skyrockets on FDA's Orphan Drug Tag for Cancer Therapy
AMLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amylyx Pharmaceuticals (AMLX) Upgraded to Buy: What Does It Mean for the Stock?
Other News for AMLX
AMLX makes New 52 Week Closing High on September 19
New 52 Week Closing High appears for AMLX after 3.76% move
New 52 Week Closing High appears for AMLX after 6.77% move
New 52 Week Closing High appears for AMLX after 0.93% move
Goldman Sachs Raises Price Target for AMLX to $20, Maintains Buy Rating | AMLX Stock News